FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1

Forkhead Box F1 (FOXF1) has been recently implicated in cancer progression and metastasis of lung cancer and breast cancer. However, the biological functions and underlying mechanisms of FOXF1 in the regulation of the progression of colorectal cancer (CRC) are largely unknown. We showed that FOXF1 was up-regulated in 93 paraffin-embedded archived human CRC tissue, and both high expression and nuclear location of FOXF1 were significantly associated with the aggressive characteristics and poorer survival of CRC patients. The GSEA analysis showed that the higher level of FOXF1 was positively associated with an enrichment of EMT gene signatures, and exogenous overexpression of FOXF1 induced EMT by transcriptionally activating SNAI1. Exogenous overexpression FOXF1 functionally promoted invasion and metastasis features of CRC cells, and inhibition of SNAI1 attenuates the invasive phenotype and metastatic potential of FOXF1-overexpressing CRC cells. Furthermore, the results of the tissue chip showed that the expression of FOXF1 was positively correlated with SNAI1 in CRC tissues chip. These results suggested that FOXF1 plays a critical role in CRC metastasis by inducing EMT via transcriptional activation of SNAI1, highlighting a potential new therapeutic strategy for CRC.

[1]  P. Carlsson,et al.  Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production , 2006, Development.

[2]  Pang-Kuo Lo,et al.  Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. , 2010, Cancer research.

[3]  Sung-Hoon Kim,et al.  Role of Forkhead Box Class O proteins in cancer progression and metastasis. , 2017, Seminars in cancer biology.

[4]  Yuqi Cai,et al.  FOXF1 Transcription Factor Is Required for Formation of Embryonic Vasculature by Regulating VEGF Signaling in Endothelial Cells , 2014, Circulation research.

[5]  Y. Nie,et al.  Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression , 2014, Hepatology.

[6]  A. Cano,et al.  Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor , 2005, Journal of Cell Science.

[7]  A. Jemal,et al.  Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[8]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[9]  Hushan Yang,et al.  Genetic variations in colorectal cancer risk and clinical outcome. , 2014, World journal of gastroenterology.

[10]  Gisela Nilsson,et al.  Forkhead Box F1 promotes breast cancer cell migration by upregulating lysyl oxidase and suppressing Smad2/3 signaling , 2016, BMC Cancer.

[11]  E. Lam,et al.  The emerging roles of forkhead box (Fox) proteins in cancer , 2007, Nature Reviews Cancer.

[12]  Zack Z Wang,et al.  Epithelial–mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis , 2017, Journal of cellular physiology.

[13]  J. Cicenas,et al.  KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma , 2017, Medical Oncology.

[14]  Yan Xu,et al.  FOXF1 maintains endothelial barrier function and prevents edema after lung injury , 2016, Science Signaling.

[15]  A. Mercurio,et al.  The epithelial-mesenchymal tansition (EMT) and colorectal cancer progression , 2005, Cancer biology & therapy.

[16]  Yanqing Ding,et al.  MicroRNA-30 b functions as a tumour suppressor in human colorectal cancer by targeting KRAS , PIK 3 CD and BCL 2 , 2014 .

[17]  K. Miyazaki,et al.  Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma , 2005, British Journal of Cancer.

[18]  X. Bian,et al.  HOXB7 as a Prognostic Factor and Mediator of Colorectal Cancer Progression , 2011, Clinical Cancer Research.

[19]  Mohini Singh,et al.  EMT: Mechanisms and therapeutic implications , 2017, Pharmacology & therapeutics.

[20]  Yanqing Ding,et al.  MicroRNA‐30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2 , 2014, The Journal of pathology.

[21]  P. Carlsson,et al.  Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. , 1994, The EMBO journal.

[22]  Li Liang,et al.  FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways. , 2014, Cancer letters.

[23]  R. Medema,et al.  Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis. , 2014, The Journal of clinical investigation.

[24]  J. Shay,et al.  Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer , 2017, Journal of the National Cancer Institute.

[25]  T. Kalin,et al.  Forkhead Box F1 Is Essential for Migration of Mesenchymal Cells and Directly Induces Integrin-Beta3 Expression , 2007, Molecular and Cellular Biology.

[26]  W. M. Pruitt,et al.  Wnt/β Catenin-Mediated Signaling Commonly Altered in Colorectal Cancer. , 2016, Progress in molecular biology and translational science.

[27]  Yan Ding,et al.  FOXC2 promotes colorectal cancer metastasis by directly targeting MET , 2014, Oncogene.

[28]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[29]  G. Cao,et al.  Downregulation of SAFB Sustains the NF-κB Pathway by Targeting TAK1 during the Progression of Colorectal Cancer , 2017, Clinical Cancer Research.

[30]  M. Fernö,et al.  Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. , 2010, Cancer research.

[31]  K. Helin,et al.  Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor , 2008, Molecular and Cellular Biology.

[32]  A. Barski,et al.  FOXF1 transcription factor promotes lung regeneration after partial pneumonectomy , 2017, Scientific Reports.

[33]  M. Nieto,et al.  The Snail genes as inducers of cell movement and survival: implications in development and cancer , 2005, Development.

[34]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[35]  P. Carlsson,et al.  Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4 , 2007, Development.

[36]  C. Antonescu,et al.  FOXF1 Defines the Core-Regulatory Circuitry in Gastrointestinal Stromal Tumor. , 2018, Cancer discovery.

[37]  De-fei Hu,et al.  Decreased FOXF 1 promotes hepatocellular carcinoma tumorigenesis , invasion , and stemness and is associated with poor clinical outcome , 2016 .

[38]  E. Engleman,et al.  Orthotopic mouse model of colorectal cancer. , 2007, Journal of visualized experiments : JoVE.

[39]  G. Berx,et al.  Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.

[40]  B. Aronow,et al.  The transcription factor FOXF 1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK 5 , 2016 .

[41]  P. Carlsson,et al.  The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. , 2001, Development.

[42]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[43]  M. Fraga,et al.  The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors , 2016, Journal of Cell Science.

[44]  Sabine Tejpar,et al.  KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. , 2011, The Lancet. Oncology.

[45]  M. Fraga,et al.  The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors , 2003, Journal of Cell Science.

[46]  K. Edlund,et al.  Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. , 2010, Cancer research.

[47]  Chen Huang,et al.  FOXM1 and its Oncogenic Signaling in Gastric Cancer. , 2015, Recent patents on anti-cancer drug discovery.

[48]  Cheng-Wen Wu,et al.  FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells , 2014, Oncotarget.

[49]  De-fei Hu,et al.  Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome , 2016, OncoTargets and therapy.

[50]  B. Zhou,et al.  The Role of Snail in EMT and Tumorigenesis. , 2013, Current cancer drug targets.

[51]  Jianbiao Zhou,et al.  P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation. , 2015, World journal of gastroenterology.

[52]  Y. Toiyama,et al.  FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer , 2016, Clinical Cancer Research.

[53]  Yanqing Ding,et al.  TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway , 2015, Oncotarget.

[54]  B. Aronow,et al.  The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5 , 2016, Science Signaling.